1 prostate cancer: A Success Story Prostate cancer is the most common cancer in human beings. That is, even though prostate cancer occurs only in men, the number of men with prostate cancer exceeds the combined numbers of men and women with any other type of cancer. For example, there are more men with prostate cancer than the combined number of men and women with lung cancer or colon cancer. There are more men with prostate cancer than women with breast cancer. Prostate cancer is the second most common cause of cancer death in men. Therefore, not only is prostate cancer extremely common, it is a fatal illness for thousands of American men yearly.... [the] inaccurate notion that prostate cancer is a harmless old man's disease has been dispelled... The formerly popular but inaccurate notion that prostate cancer is a harmless old man's disease has been dispelled, at least for the majority of enlightened physicians. There were two main reasons for the old erroneous view of prostate cancer. First, as late as the mid 20th century, the life span of the average American man was significantly shorter than it is presently. Many men with prostate cancer died at a younger age of heart disease. Secondly, prostate cancer screening methods including PSA blood testing now allow the diagnosis of prostate cancer 4 5 years earlier than before. Therefore, physicians recognized that prostate cancer often grows slowly. Recognition of this fact may have given rise to the false impression that treatment might not be required. At first glance, this information might seem to support the false conclusion that prostate cancer is a harmless disease. However, when the facts are examined more closely another reality becomes clear. Contrary to the notion that prostate cancer is harmless, the above two reasons support the very logical opposite conclusion that prostate cancer indeed is a dangerous disease. Men now live longer, thanks to advances in medicine such as cardiac surgery, cardiac stents, cholesterol medications, other cancer treatments, antibiotics and the like. Since men now live longer they now have both a greater chance of developing prostate cancer, as well as a greater chance of suffering the ill effects of the disease, including death from prostate cancer. In the time after the widespread use of effective treatment for heart disease and before prostate cancer screening became widely practiced, the population aged while the complications of prostate cancer became more evident. However, prostate cancer screening efforts, including PSA testing, now allow the detection of prostate cancer at an earlier stage thus allowing for cure of prostate cancer using modern techniques. Therefore, the notion that prostate cancer screening has shown prostate cancer to be a benign disease is absolutely false. To the contrary, cancer detection through prostate cancer screening allows the detection of an earlier stage of cancer at an earlier point in the lives of men who, because of advances in this and other fields of medicine, now have a longer life expectancies. Obviously, detection of cancer at an early stage increases the odds of curing cancer with treatment. Therefore, the preponderance of evidence suggests that without prostate cancer screening, the harmful effects of prostate cancer should increase as men live longer. However, thanks to prostate cancer screening efforts, the disease is now commonly detected early and cured with treatment.
2 ... prostate cancer screening and early treatment save lives! These facts have been borne out by several observations including published prostate cancer screening studies demonstrating a decreased incidence of advanced prostate cancer, confirming the early detection theory, and decreased mortality rates (decreased death rates from prostate cancer). Additionally, population based studies have demonstrated decreased mortality rates from prostate cancer in large groups of men who have undergone screening. While the cynic presumes that men should not be treated for prostate cancer, enlightened physicians look at this data from recent randomized clinical trials and see that prostate cancer is a malignant condition and prostate cancer screening and early treatment save lives!... multiple studies examining the quality of life after prostate cancer treatment indicate excellent results of treatment. Cynics also formerly complained that prostate cancer screening should not be performed because the early detection of prostate cancer resulted in too many men undergoing unnecessary cancer treatment. Skeptics have implied that the treatment for prostate cancer was worse than the cancer itself. The facts do not bear this out. In fact, multiple studies examining the quality of life after prostate cancer treatment indicate excellent results of treatment. The studies indicate that there is little if any quality of life change after treatment. Additionally, most men emotionally benefit from treatment by knowing that they no longer have cancer! In recent years as prostate cancer has become diagnosed earlier in the course of the disease, the complication rates of treatment have likewise decreased. The ultimate proof of the benefit of early cancer detection and treatment is a decreased complication rate and death rate from prostate cancer, combined with preserved quality of life after treatment. These are the facts!... selenium and vitamin E supplementation may be beneficial in preventing prostate cancer. The incidence of prostate cancer diagnosis is about one of every one hundred men in their 40s and 50's and about one of every eight men in their 60s and 70s. There is a greater likelihood of being diagnosed with prostate cancer in men with family histories of prostate cancer. For a man having two relatives with prostate cancer, the risk of being diagnosed with prostate cancer is about five times the risk of the average man. Clearly, there is a genetic predisposition for the development of prostate cancer and prostate cancer runs in families. Additionally, African American men may have a increased incidence of prostate cancer. High fat diets and diets low in the mineral selenium may contribute to the development of prostate cancer. Some studies have also suggested that selenium and vitamin E supplementation may be beneficial in preventing prostate cancer. Prostate specific antigen (PSA) is a protein enzyme found in the prostate, in urine and in the blood stream of men with prostate glands. As the name implies, PSA is prostate specific but not specific for prostate cancer. Testing prostate and urinary PSA has not proven useful. However, studies have shown that bloodstream PSA is often elevated in men with prostate cancer. Doctors have more experience with the use of this blood test than with the use of any other cancer detecting blood test. PSA is used both for prostate cancer screening and prostate cancer follow up testing. In fact, when men undergo prostate cancer screening including PSA testing in successive years, detected cancers are usually smaller and more amenable to treatment for cure.
3 ... a man with an elevated PSA is twice as likely to have cancer as a woman with an abnormal mammogram. PSA is an effective screening tool for prostate cancer. In fact, a man with an elevated PSA is twice as likely to have cancer as a woman with an abnormal mammogram. On average, PSA allows the detection of prostate cancer some 4 5 years before the cancer could otherwise have been detected. When men are tested at the recommended ages for cancer screening, PSA testing often allows the detection of prostate cancer while the cancer is still confined to the prostate gland. At this early stage, prostate cancer is more often curable. Without PSA testing, however, prostate cancer is often detected only after it has spread beyond the confines of the prostate, making cure of the cancer practically impossible. Many urology specialists believe that normal PSA values depend on the age of the patient. Commonly used abnormal PSA ranges are as follows: (1) men in their 40s > 2.5, (2) men in their 50s > 3.5, (3) men 60 or older > 4.0. Some say that men 70 or older may have PSA values up to 6.5. Other experts feel that no man should have a serum PSA > 2.5. Obviously, there is no exact range of normal that perfectly discriminates between a man who has prostate cancer and a man who does not.... a better way of using PSA to screen for prostate cancer is... PSA velocity. A better way of using PSA to screen for prostate cancer is monitoring of repeated PSA blood tests perhaps every 6, 12 or 24 months (depending on the clinical situation) so that new PSA values may be compared with established PSA values for the same patient over time. This form of assessment is sometimes called PSA velocity. Determination of the rate of increase in serum PSA may be an even more useful means of early detection of prostate cancer. Using PSA velocity assessment prostate biopsies may used to detect prostate cancer even when the total PSA value is in the normal range. Some 25 percent of prostate cancers are detected when the total PSA value is normal. Another effective method for PSA prostate cancer screening is the determination of a portion of total blood PSA that his not protein bound. This so called "free" PSA ratio ideally should be greater than 25 percent in men with total PSA values between 4 and 10. Determination of free PSA ratio and may be best suited for men with elevated total PSA values having undergone prior negative prostate biopsies. In such cases, an abnormal free PSA ratio may guide the urologist to perform additional biopsies. Interestingly, it has been shown that decreasing free PSA is the first sign of prostate cancer, occurring up to 5 years before the total PSA increases. PSA is not a perfect test for the detection of prostate cancer. There are no perfect tests in medicine. Some men with elevated PSA values may not have prostate cancer. Likewise, some men with normal PSA values actually harbor prostate cancer. Approximately 25 percent of men who are diagnosed with prostate cancer have PSA levels in the normal range. In these cases, prostate cancer is detected by digital rectal examination of the prostate, by removal of a portion of the prostate during surgery for prostate enlargement, by monitoring of PSA velocity or by other methods. An even more established method of PSA utilization is for the follow up in patients after treatment for prostate cancer. PSA levels guide clinical decision making after every form of treatment. In general,
4 PSA levels accurately reflect the status of the cancer. Additional methods of cancer monitoring include bone and Prostascint scanning for metastatic disease. When there is a suspicion of prostate cancer, men generally undergo transrectal ultrasound guided needle biopsies of the prostate. This is a procedure performed in the urologist's office. Because procedure is anxiety provoking and uncomfortable, sedation and pain medications are usually used. With adequate premedication and communication on the part of the urologist performing the examination, most patients have no complaints concerning the procedure. Ultrasonography allows visualization of the prostate such that biopsies may be directed into specific areas of the prostate which most commonly harbor the cancer and areas of the prostate which demonstrate visible abnormalities on the ultrasound image. At the Urology Center, our physicians personally perform both the ultrasound examination and the biopsies. There is no substitute for personal involvement [by the urologist] with this extremely important process. A great deal of experience in ultrasound imaging of the prostate is necessary to positively diagnose or exclude the presence of prostate cancer. At some urology clinics, the ultrasound examination is relegated to a technician. In those circumstances, the urologist may come into the ultrasound room briefly, only to oversee the short portion of the procedure when the actual biopsies are performed. In these circumstances, when the urologist has not performed the ultrasound examination, error may be introduced into the process. That is, prostate cancer may be missed. At the Urology Center, our physicians personally perform both the ultrasound examination and the biopsies. No technician is involved. We have performed prostate biopsies on thousands of patients. There is no substitute for personal involvement with this extremely important process. The prognosis and treatment options for prostate cancer depend on the stage and grade of the cancer. Therefore, once prostate cancer is diagnosed, the tumor must be staged. Prostate cancer staging may involve bone scanning, CT scanning, additional blood testing, and lymph node dissection. Prostate cancer commonly first spreads to large glands near the prostate called the seminal vesicles. The seminal vesicles may be biopsied using transrectal ultrasonography. Prostate cancer also commonly spreads to lymph nodes within the pelvis. CT scanning can detect enlargement of these lymph nodes after which CT guided needle biopsies may prove the presence of cancer within the lymph nodes. Physicians at the Urology Center are experienced with laparoscopic pelvic lymph node surgery and the appropriate indications to use this specialized diagnostic tool. However, the lymph nodes may contain cancer even if the lymph nodes are not enlarged on a CT scan. In such cases, lymph node biopsy may be necessary, either by means of open surgical removal of the lymph nodes or by laparoscopic lymph node dissection. The need for these tests must be determined after careful analysis by and urologist who has knowledge of current prostate cancer evaluation and management methods, as well as experience with these methods. Laparoscopic pelvic lymph node resection is commonly performed in limited circumstances when there is significant suspicion for
5 cancer involvement of the pelvic lymph nodes. Laparoscopy involves placement of thin instruments through the abdominal wall in order to perform operative procedures without the need for large skin incisions. Laparoscopic pelvic lymph node resection allows for the accurate determination of the presence or absence of prostate cancer within the pelvic lymph nodes, without the morbidity associated with a large surgical skin incision. Physicians at the Urology Center are experienced with laparoscopic pelvic lymph node surgery and the appropriate indications to use this specialized diagnostic tool. Once prostate cancer has been accurately diagnosed and staged, treatment may begin. The choice of treatment greatly depends upon the stage and grade of the cancer and personal choices of the patient. When prostate cancer has escaped the prostate gland and spread beyond the prostate, it is presently considered incurable. However, multiple treatment options exist that may delay the progression of the cancer for many years in many such cases. In these cases treatment options include simple observation without treatment, hormonal ablation and chemotherapy. Chemotherapy for prostate cancer is an old idea but until recently, chemotherapy has not proven beneficial. Chemotherapy is now generally reserved for advanced cases of prostate cancer which no longer respond to other treatments. On the other hand, hormonal therapy is the standard of care for advanced prostate cancer. The risks and potential benefits of each of these forms of treatment must be carefully weighed. The primary issue... is whether or not hormonal therapy should be started immediately or... postponed until later in the course of the disease. In most prostate cancers, the vitality of the majority of cancer cells is dependent on stimulation by male hormones (androgens) which are produced in the testicles (testosterone) and, to a lesser degree, in the adrenal glands. The primary issue to be considered in cases where patients have decided against undergoing potentially curative cancer treatment, is whether or not hormonal therapy should be started immediately or whether hormonal therapy should be postponed until later in the course of the disease. At first glance, even the question of delaying treatment might seem irrational. However, hormonal therapy may have significant side effects and the benefits of early treatment versus later treatment has not been established with absolute certainty. Just within the last several years, information has come to the forefront indicating that early hormonal therapy may delay the progression of prostate cancer and may increase survival time. Again, the question is whether or not the side effects of hormonal therapy are worth the potential benefit of increased survival time. Side effects of hormonal therapy may include impotence, decreased libido, gastrointestinal upset, breast swelling and tenderness, hot flashes, hair loss, deterioration of muscle mass and osteoporosis. Thus, patients with prostate cancer not confined to the prostate must individually decide whether or not they will undergo hormonal therapy early or later in the course of the disease. Patients with prostate cancer not confined to the prostate must also decided which type of hormonal therapy they will use. Three broad hormonal therapy options are surgical hormonal therapy vs. medical hormonal therapy vs. combined surgical and medical hormonal therapy. Testosterone is a male hormone produced primarily by the testicles. A much smaller amount of male hormone is produced in the adrenal glands. Surgical removal of the testicles, (orchiectomy), significantly reduces the available testosterone. Likewise, use of luteinizing hormone releasing hormone (LHRH) agonist medications such as leuprolide (Lupron and Viadur) and goserelin (Zoladex) reduce testosterone to levels as low as levels produced by surgical orchiectomy. Therefore, the standard choices, surgical
6 orchiectomy, leuprolide and goserelin are thought to be nearly equivalent with regard to their effects on testosterone, their effects on prostate cancer and their side effects. However, leuprolide and goserelin are reversible treatments, whereas surgical orchiectomy is not reversible obviously. Another question to be answered in patients considering hormonal therapy for prostate cancer not confined to the prostate gland concerns whether or not to use medications called antiandrogens, that block the effects of androgens produced in the adrenal glands. Without the use of the antiandrogen medications in addition to goserelin, leuprolide or orchiectomy, the adrenal glands continue to produce male hormone. Even this small amount of androgen may allow growth stimulation of prostate cancer cells. There are several categories of medications which may block the effects of adrenal androgen hormones and testicular hormone (testosterone). In the United States, the primary antiandrogen medications used for this purpose are flutamide (Eulexin) and bicalutamide (Casodex). Neither of these medications decrease male hormone levels. Instead, they prevent male hormone from entering prostate cancer (and other) cells, thus preventing androgen stimulation of prostate cancer.... there has been a great deal of disagreement among physicians and scientists as to whether the addition of antiandrogens provides significant benefits... In the past there has been a great deal of disagreement among physicians and scientists as to whether the addition of antiandrogens provides significant benefits to prostate cancer patients. Some studies have shown a benefit in increased survival of patients using these medications along with standard hormonal treatments (like orchiectomy or leuprolide/goserelin). Other studies have shown little if any benefit; however, until recently most studies have only looked at patients with more advanced cancer. A recent very large clinical trial of prostate cancer patients showed that the addition of bicalutamide to standard hormonal treatments reduced the risk of cancer progression (spread) by 42 percent. Whether or not this will result in a survival benefit (fewer deaths from prostate cancer) is presently unknown. Another question concerns whether or not antiandrogens like flutamide or bicalutamide should be used alone, without the standard hormonal treatments like surgical orchiectomy, leuprolide and goserelin. Of course the main reason that this question has been raised is the fact that antiandrogen medications have less deleterious effects with regard to sexual dysfunction (loss of libido and erectile dysfunction). Recently, a relatively small study of patients of about 500 prostate cancer patients showed promising results with the use of bicalutamide alone. The study showed that bicalutamide 150 mg/day alone was as good as surgical orchiectomy alone in patients with locally advanced prostate cancer, in terms of mortality and progression of disease. In the recent clinical study and other studies mild breast enlargement and pain were common side effects of bicalutamide. Hot flashes are common with leuprolide, goserelin surgical orchiectomy. However, overall, the group of patients using bicalutamide alone seemed to have a better quality of life, including better sexual function, as compared to the group of patients having undergone orchiectomy. Low dose radiation treatment to the breast tissue is unquestionably helpful in preventing painful breast swelling in patients using bicalutamide and flutamide. However, the radiation must be given before treatment is started.... most any form of hormonal therapy may cause osteoporosis.
7 It appears that most any form of hormonal therapy may cause osteoporosis. Until recently this problem was not well recognized or at least not well publicized. Now that many patients are using hormonal therapy early on in the course of prostate cancer disease, many doctors have become concerned about the longtime negative effects of hormonal therapy, including the long term effects on bone. Several new medications have been developed to combat this problem. Men on long term hormonal therapy may be monitored for osteoporosis using bone densitometry tests. For men with clinically localized prostate cancer and a life expectancy of at least ten years potentially curative treatment options should be considered. Three broad categories of potentially curative treatment include surgery, radiation therapy and cryotherapy. Cryotherapy ablation of the prostate implies freezing of the prostate gland. Cryotherapy has been used for many years for the treatment of prostate cancer but recent advances in the technique make cryotherapy an option for some patients. Presently, many urologists feel that cryotherapy may be considered for patients who would otherwise undergo radiation therapy. At one time... [radiation therapy] was the most popular form of treatment. Radiation therapy has been used for many years for the treatment of prostate cancer. At one time it was the most popular form of treatment. The basic types of radiation therapy are external beam radiation therapy, brachytherapy ("seeds") and combined external beam and brachytherapy. External beam radiation therapy involves radiation delivered from outside the body. This treatment has been used for many years but, as for every other treatment for prostate cancer, refinements of technique have decreased its complications. Like external beam radiation, brachytherapy has also been used for many years. The technique involves placement of radioactive "seeds" into the prostate gland. Just as for most other treatments for prostate cancer, refinements of technique have improved its results and decreased its complications. Potential complications of radiation therapy include urinary incontinence, rectal irritation, bladder irritation, urinating difficulties, gastrointestinal side effects, urethral scarring, impotence, bloody urine and others. However, the most disturbing complication of radiation therapy (or any therapy for that matter) treatment failure with persistent or progressive prostate cancer, even after treatment. While some studies reveal excellent early results of radiation therapy treatment, others show treatment failure and persistent or progressive prostate cancer in up to percent of cases. As with every other treatment, the results largely depend on the grade and stage of the cancer at the time treatment is initiated. Once again, prostate cancer screening is important. Surgical treatment of prostate cancer entails removal of the entire prostate gland and the glands near the prostate the seminal vesicles. The prostate may be approached in several ways: through the lower abdominal wall (radical retropubic prostatectomy), through the perineum between the scrotum and anal opening (radical perineal prostatectomy) or by placement of thin telescopic instruments through the abdominal wall (laparoscopic radical prostatectomy). Each variation offers potential advantages for certain patients. Likewise, each surgical variation has disadvantages and potential complications. For example, while some surgeons feel that perineal prostatectomy allows a speedy recovery, some urologists feel that they can not effectively remove all of the cancer in or around the prostate using this approach. Furthermore, it is not possible to assess the pelvic lymph nodes and remove them when performing a perineal prostatectomy.
8 Laparoscopic prostatectomy has the potential advantage of a quick recovery and this approach also allow for assessment of the pelvic lymph nodes. However, laparoscopic prostatectomy has its own potential problems, not the least of which is increased length of time of the operation, thereby exposing the patient to additional anesthesia. Furthermore, some laparoscopic surgical cases are unsuccessful, at which time the patient must additionally undergo the standard open surgical incision. Furthermore there are no long term reports concerning success rates of this type of surgery. Surgeons at the Urology Center do perform laparoscopy but we feel that laparoscopic radical prostatectomy cannot be considered the surgical standard of care at the present time. The surgeons at the Urology Center... have performed hundreds of these [radical prostatectomy] procedures with excellent results. The surgeons at the Urology Center generally perform prostate cancer surgery by means of the radical retropubic prostatectomy. We have performed hundreds of these procedures with excellent results. With the patient completely asleep, a short skin opening is made just above the pubic bone, allowing the operating surgeons to evaluate all of the structures which may contain cancer and require removal, including the pelvic lymph nodes, the prostate and the seminal vesicles. Lymph node removal decisions are made based upon PSA levels, the pathological grade of the prostate cancer, the volume of the cancer the direct assessment of the pelvic lymph nodes at the time of surgery. Commonly, pelvic lymph node removal is not required thereby decreasing the surgical complication rate. Specifically, the potential complication of the development of a collection of lymph fluid within the pelvis (lymphocele formation) may be largely avoided. Many urologists feel that the radical retropubic approach offers the best visualization of the prostate and seminal vesicles, potentially allowing more efficient removal of all the cancer. For many reasons, the radical retropubic prostatectomy is the procedure of choice for the majority of urologic surgeons. Of course, the choice of the operative approach depends upon the personal experience of the operating surgeons and the Urology Center surgeons have a large experience with radical retropubic prostatectomy. No matter the surgical approach, when prostate cancers are detected in men who have followed the guidelines for prostate cancer screening, radical prostatectomy results in cure of the prostate cancer in the majority of cases.... patients undergoing radical retropubic prostatectomy may expect a two night hospital stay with only minor postoperative discomfort. Our patients undergoing radical retropubic prostatectomy may expect a two night hospital stay with only minor postoperative discomfort. Approximately 90 percent of patients go home from the hospital on the second postoperative day. Occasionally, patients may choose to go home only after one night in the hospital and occasionally an older patient may stay longer. The secret to speedy recovery after surgery of this type is thorough preoperative education (concerning what to expect during the brief hospitalization) and excellent pain control with an early return to physical activity. In fact, most patients are up and out of bed or walking just several hour after surgery! One of two contemporary methods of postoperative pain relief are used. Most commonly patients use a patient controlled analgesia (PCA) device which allows the delivery of pain medication with the press of a button. This is totally controlled by the patient. Alternatively, some patients choose an
9 epidural anesthetic which entails placement of a small catheter around the nerves in the lower part of the back. The catheter is placed at the time of surgery but postoperatively pain medication is continuously delivered to the lower part of the back. This generally results in the total absence of pain after the surgery. Of course, eventually the PCA or epidural must be discontinued. Most patients thereafter experience some relatively mild soreness which is easily controlled using a non narcotic oral medication, sometimes supplemented with a mild oral narcotic type medication. In either case, patients are generally eating and walking the halls of the hospital no later than the morning of the day following surgery. Without a doubt the most common grievance patients have with prostate surgery relates to wearing of a the catheter in the bladder. Catheter discomfort can be managed with special medications and irritation improves with time. While some men experience painful bladder spasms, other patients have no complaints with regard to the catheter. Unfortunately, no matter which surgical technique is used, wearing a catheter after the surgery is absolutely mandatory. However, using the radical retropubic technique, patients generally only have to use the catheter about ten days. However we have known other physicians to keep the catheter in place routinely for three six weeks. Obviously, patients go home with the catheter and later have it removed in the doctors office or by a home health care nurse. Absolutely every form of prostate cancer treatment has been linked to the development of erectile dysfunction (ED). All prostate cancer treatments have side effects. There is no known prostate cancer treatment which does not cause sexual dysfunction. Absolutely every form of prostate cancer treatment has been linked to the development of erectile dysfunction (ED). Patients may expect erectile dysfunction in up to 50 percent of the cases after radiation therapy and in up to 100 percent the cases after cryotherapy, standard hormonal therapy and prostate cancer surgery. In our experience approximately 50 percent of patients undergoing the nerve sparing procedure may continue to have normal erections after surgery. Any type of prostate cancer surgery can cause erectile dysfunction. However, in selected cases, sexual function may be preserved by a surgeon experienced in the procedure known as nerve sparing radical prostatectomy. Using this procedure, tiny nerves which run directly around the prostate and seminal vesicles may be preserved during surgery, allowing patients to continue to have penile erections postoperatively. In our experience approximately 50 percent of patients undergoing the nerve sparing procedure may continue to have normal erections after surgery. Otherwise, patients commonly require Viagra or other methods of erectile dysfunction treatment after surgery. Furthermore, of patients who do develop ED after surgery, a greater percentage of those patients having undergone a nerve sparing radical prostatectomy may respond to Viagra, as opposed to those having a standard non nerve sparing surgery.... be wary of surgeons who claim that they "always" perform nervesparing radical prostate cancer surgery...
10 Patients should be wary of surgeons who claim that they "always" perform nerve sparing radical prostate cancer surgery or that they will decide whether or not to perform a nerve sparing procedure only during an operation. A nerve sparing procedure cannot and should not be performed in a very considerable number of men with prostate cancer. Reasons include high grade cancer, locally advance stage of cancer, patients with ED or marginal erectile function, unwillingness on the part of the patient to accept a low risk of incomplete removal of all of the cancer and, last but not least, the location of the cancer within the prostate. Some urologists haphazardly label the small pieces of tissue removed form the prostate during the prostate biopsy session such that no one can tell the exact spot that the cancer is located within the gland. This may limit that urologist's ability to guide patients with regard to making decisions concerning whether or not to recommend a nerve sparing surgery. Also, be cautious of surgeons who tell their patients the a decision concerning a nerve sparing procedure will be made based solely on findings during surgery. Generally, the decision can be made well before the operation, although in uncommon cases the decision to perform a nerve sparing procedure may be changed due to adverse findings at the time of the operation. In summary, be cautious of any surgeon who claims that he or she performs nerve sparing radical prostatectomy procedures, yet fails to completely map out the entire prostate when performing prostate biopsies. If mapping of the prostate is properly done, the results are recorded on the report from the pathologist who interpreted the biopsy results. Many patients who decide not to undergo a nerve sparing procedure ultimately opt to undergo placement of a four piece inflatable penile prosthesis. In fact, the reservoir portion of a penile prosthesis can be safely placed at the time of the radical retropubic prostatectomy, without making any additional skin incision. This may not be the case with other forms of prostate cancer surgery. Of course there are many other methods of ED treatment, but beyond Viagra, there are none with satisfaction rates as high as a four piece inflatable penile prosthesis. (Please visit our Male Urology and Erectile Dysfunction Center of Excellence for additional information.) Additionally, prostate cancer surgery, radiation and cryotherapy may also result in urinary incontinence, accidental leakage of urine. Of these treatments, prostate cancer surgery more commonly results and urinary incontinence. Some studies have reported incontinence in the majority of men undergoing prostate cancer surgery. However, most reports indicate that less than two percent have incontinence severe enough to undergo corrective surgery. The younger the patient the less the chance of incontinence. Incontinence may be treated with medication, exercises, behavioral techniques, biofeedback training and surgery. Surgical treatments are reserved for severe cases. This treatment may entail cystoscopy with injection of a bulking agents such as collagen within the walls of the urethra. Pubourethral sling surgery is an effective alternative. However, the most effective way to manage postoperative stress urinary incontinence in men having undergone prostate cancer surgery is placement of an artificial urinary sphincter (AUS).... the most effective way to manage postoperative stress urinary incontinence... [is] an artificial urinary sphincter (AUS). The artificial urinary sphincter involves placement of a tiny donut like fluid filled cuff device around the urethra. The cuff is connected to a tiny pump located within the scrotum. By squeezing the pump several times, fluid is transferred from the cuff to a fluid reservoir deflating the cuff, thereby allowing the urine to pass through the urethra. Normal voiding of urine results. Fluid then automatically refills
11 the cuff, occluding the urethra, preventing unwanted urine leakage. The results of the artificial urinary sphincter procedure are excellent, with most patients reporting complete dryness or drastic improvement. In summary, rapid progress is being made with regard to the diagnosis and treatment prostate cancer. Additionally, studies are ongoing investigating methods of prostate cancer prevention. Worldwide, more men than ever are undergoing prostate cancer screening. Prostate cancer screening is resulting in earlier detection of prostate cancer at the stage when the cancer may be treated for cure. In fact, there are clear indications that the mortality rate from prostate cancer is decreasing. Early indications strongly suggest that this progress is the result of a combination of prostate cancer screening with early detection and treatment. Furthermore, the complications of prostate cancer treatment are clearly decreasing with refinements of medication, radiation therapy, cryotherapy and surgical techniques. While every form of prostate cancer treatment has been associated with the development of erectile dysfunction, this problem is readily treatable such that no man should have to live with this problem. The physicians at the Urology Center not only have extensive experience with the evaluation and treatment prostate cancer, but they also have experience with the prevention and management of male incontinence and erectile dysfunction concerns. The author, H. Stephen Watson, M.D., is a certified diplomate ot the American Board of Urology. Dr. Watson has helped hundreds of men with prostate cancer. If you desire additional information, please call Dr. Watson at (985) or (985) or visit
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
Prostate Cancer Definition Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around
Radiation Therapy for Prostate Cancer Introduction Cancer of the prostate is the most common form of cancer that affects men. About 240,000 American men are diagnosed with prostate cancer every year. Your
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of
AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options INTRODUCTION This booklet describes how prostate cancer develops, how it affects the body and the current treatment methods. Although
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
Prostate Cancer Screening A Decision Guide for African Americans This booklet was developed by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). Published
about prostate health. ABOUT THE DISEASE Prostate cancer is one of the most common types of cancer in American men, with more than 200,000 new cases diagnosed annually. It is also the second-leading cause
Testing for Prostate Cancer Information for men and their families Published by the New Zealand Guidelines Group Contents Should you be tested for prostate cancer? 1 What is the prostate? 2 Do you have
A Woman s Guide to Prostate Cancer Treatment Supporting the man in your life Providing prostate cancer support and resources for women and families WOMEN AGAINST PROSTATE CANCER A Woman s Guide to Prostate
Living with Prostate Cancer A Common Cancer in Men If you ve been diagnosed with prostate cancer, it s normal to be concerned about your future. It may help you to know that this disease can often be cured
Chapter 3. Treatment Options With contributions from Nancy L. Brown, Ph.D., Palo Alto Medical Foundation Research Institute; Patrick Swift, M.D., Alta Bates Comprehensive Cancer Program; D. Jeffrey Demanes,
What You Need to Know About Your Partner s Prostate Cancer. A Guide for Wives, Partners, and the Men They Love. Providing Support for Your Partner Prostate cancer can be a physical and emotional challenge
Screening for Prostate Cancer It is now clear that screening for Prostate Cancer discovers the disease at an earlier and more curable stage. It is not yet clear whether this translates into reduced mortality
X-Plain Prostatectomy Reference Summary Introduction Prostate cancer is a very common condition that affects men. The rate of occurrence of prostate cancer increases with age. Prostatectomy is a surgery
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
Patient & Family Guide 2015 Hormone Therapy for Prostate Cancer www.nshealth.ca Hormone Therapy for Prostate Cancer What is the prostate? The prostate is one of the male sex glands. It makes seminal fluid
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
Thomas A. Kollmorgen, M.D. Oregon Urology Institute None 240,000 new diagnosis per year, and an estimated 28,100 deaths (2012) 2 nd leading cause of death from cancer in U.S.A. Approximately 1 in 6 men
male sexual dysfunction lack of desire Both men and women often lose interest in sex during cancer treatment, at least for a time. At first, concern for survival is so overwhelming that sex is far down
Diagnosis and Treatment Table of Contents Introduction... 1 Patient and Coach Information... 1 About Your Prostate... 1 What You Should Know About Prostate Cancer... 2 Screening and Diagnosis... 2 Digital
After Diagnosis: Prostate Cancer Understanding Your Treatment Options What s inside How will this booklet help me?... 3 What is the prostate?... 4 What is prostate cancer?... 4 Who gets prostate cancer?...
Understanding Prostate Cancer Guest Expert: Wm. Kevin, DO Associate Professor of Medical Oncology, Co-director of the Yale Cancer Center Prostate and Urologic Cancers Program www.wnpr.org www.yalecancercenter.org
UCLA Department Of Urology Information For Patients Radical Prostatectomy Background Prostate cancer affects the prostate gland which is located just below the urinary bladder and surrounds the urethra.
Scan for mobile link. Prostate Cancer Treatment Prostate cancer is a tumor of the prostate gland, which is located in front of the rectum and below the bladder. Your doctor may perform a physical exam,
Radical Prostatectomy Table of Contents Surgery Overview What To Expect After Surgery Why It Is Done How Well It Works Risks What To Think About References Credits Surgery Overview A radical prostatectomy
PROSTATE CANCER Get the facts, know your options Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology i What is the Prostate? Unfortunately, you have prostate
1. What is the prostate-specific antigen (PSA) test? Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. The doctor
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
PROSTATE CANCER 1. Guidelines for Screening Risk Factors Normal-risk men: No family history of prostate cancer No history of prior screening Not African-American High-risk men: Family history of prostate
The Management of Localized P R O S T A T E C A N C E R Patient Guide Based on recommendations from the Prostate Cancer Clinical Guideline Panel of the American Urological Association The AUA Foundation
The Prostate Cancer Center at Roswell Park Connects You to Nationally Recognized Experts for State-of-the-Art Treatment Options and Compassionate, Evidence-based Care Founded in 1898, Roswell Park Cancer
MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT KEYWORDS: Prostate cancer, PSA, Screening, Radical Prostatectomy LEARNING OBJECTIVES At the end of this clerkship, the medical student will be able to:
Testicular Cancer Introduction Testicles, or testes, make male hormones and sperm. The testicles are two egg-shaped organs inside the scrotum, the loose sac of skin behind the penis. You can get cancer
Peninsula Urology Center, Inc. Dieter Bruno, M.D, F.A.C.S Chris Threat, M.D. 3351 El Camino. Real, Suite 101 Atherton, CA 94027 (650) 306-1016 firstname.lastname@example.org http://www.pucenter.com/ da Vinci Prostatectomy
X-Plain Low Testosterone Reference Summary Introduction Testosterone is the most important male sex hormone. It helps the body produce and maintain adult male features. Low levels of testosterone affect
dedicated to curing BREAST CANCER When you are diagnosed with breast cancer, you need a team of specialists who will share their knowledge of breast disease and the latest treatments available. At Cancer
Prostate Cancer Information and Facts Definition Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnutsized structure that makes up part of a man's reproductive system.
Scan for mobile link. Prostate Cancer Prostate cancer is a tumor of the prostate gland, which is located in front of the rectum and below the bladder. Your doctor may perform a physical exam, prostate-specific
Prostate Cancer Treatment: What s Best for You? Prostate Cancer: Radiation Therapy Approaches I. Choices There is really a variety of options in prostate cancer management overall and in radiation therapy.
Understanding Prostate Cancer The Urology Group Guide for Newly Diagnosed Patients Advanced Care. Improving Lives. UNDERSTANDING PROSTATE CANCER The Urology Group has created this publication to provide
A.D.A.M. Medical Encyclopedia. Prostate cancer Cancer - prostate; Biopsy - prostate; Prostate biopsy; Gleason score Last reviewed: October 2, 2013. Prostate cancer is cancer that starts in the prostate
Prostate Cancer For many older men, prostate cancer may be present but never cause symptoms or problems and many men will die with their prostate cancer rather than of their prostate cancer. Yet it remains
The Clatterbridge Cancer Centre NHS Foundation Trust Hormone therapy for prostate cancer General information A guide for patients and carers Contents What is hormone therapy?... 1 How does hormone therapy
Prostate Cancer Understanding your diagnosis Prostate Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount
Prostate Cancer Screening The American Cancer Society and Congregational Health Ministry Team June Module To access this module via the Web, visit www.cancer.org and type in congregational health ministry
Prostate Cancer Screening Bruce L. Houghton, MD Associate Professor of Medicine Division of General Medicine Department of Internal Medicine Creighton University School of Medicine http://en.wikipedia.org/wiki/image:prostatelead.jpg
The Prostate-Specific Antigen (PSA) Test: Questions and Answers Key Points Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA
A918: Prostate: adenocarcinoma General facts of prostate cancer The prostate is about the size of a walnut. It is just below the bladder and in front of the rectum. The tube that carries urine (the urethra)
Associates: Dr Kim Pese Dr Kym Horsell Dr Michael Chong Dr Jason Lee The Tennyson Centre Suite 19, First Floor 520 South Road Kurralta Park SA 5037 Appointments: 08 8292 2399 Fax: 08 8292 2388 email@example.com
Coding for Prostate Cancer Tracy L. Burney, M.D. Health First Physicians Urology September 19, 2012 Prostate Cancer Basics What is the Prostate and What Does it do? Walnut sized organ found only in men.
Ali A. Kader, S. (2010). Breast cancer awareness for women and men. UCQ Nursing Journal of Academic Writing, Winter 2010, 70 76. BREAST CANCER AWARENESS FOR WOMEN AND MEN by Samar Ali A. Kader Two years
Prostatitis What is prostatitis? Prostatitis is a condition that involves inflammation of the prostate and sometimes the area around it. There are several types of prostatitis, each with a range of symptoms.
Localised prostate cancer a guide for men and their families July 2006 About this book The contents of this book are based on the NHMRC s Clinical Practice Guidelines: Evidence-based information and recommendations
For more information, please contact your local VA Medical Center or Health Clinic. U.S. Department of Veterans Affairs Veterans Health Administration Patient Care Services Health Promotion and Disease
Patient Guide ASCOInformation for People Living with Cancer HORMONE THERAPY FOR ADVANCED PROSTATE CANCER Recommendations of the American Society of Clinical Oncology Welcome The American Society of Clinical
2011 We care health Services Pankaj nagpal [ Testicular Cancer Treatment In India at Mumbai At Low cost] [Type the abstract of the document here. The abstract is typically a short summary of the contents
Prostate cancer For many older men, prostate cancer may be present but never cause symptoms or problems and men will die with their prostate cancer rather than of their prostate cancer. The younger you
Should I have a prostate-specific antigen (PSA) test to screen for prostate cancer? PATIENT DECISION AID The prostate-specific antigen (PSA) test is a blood test that is used to screen for prostate cancer.
Prostate Cancer Understanding your diagnosis Prostate Cancer Understanding your diagnosis When you first hear that you have cancer, you may feel alone and afraid. You may be overwhelmed by the large amount
Official reprint from UpToDate www.uptodate.com 2013 UpToDate The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek
Incontinence What is incontinence? Broadly speaking, the medical term incontinence refers to any involuntary release of bodily fluids, but many people associate it strongly with the inability to control
National Cancer Institute Treatment Choices for Men With Early-Stage Prostate Cancer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Things to Remember Many men with prostate
East Lancashire Surgical Robot For ALL patients in Lancashire Prostate cancer claims the life of one man every hour and by 2030 will be the most common cancer; it is already the most common male cancer.
Oncology Annual Report: Prostate Cancer 25 Update By: John Konefal, MD, Radiation Oncology Prostate cancer is the most common cancer in men, with 232,9 new cases projected to be diagnosed in the U.S. in
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
University College Hospital Hormone therapy for prostate cancer Radiotherapy Department Patient information series 10 2 If you need a large print, audio or translated copy of the document, please contact
Understanding Your Diagnosis of Endometrial Cancer A STEP-BY-STEP GUIDE Introduction This guide is designed to help you clarify and understand the decisions that need to be made about your care for the
Prostate cancer screening It s YOUR decision! For many years now, a test has been available to screen for. The test is called the prostate-specific antigen blood test (or PSA test). It is used in combination
National Cancer Institute What You Need TM To Know About Prostate Cancer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health For more publications This is only one of many free booklets
Male Breast Cancer Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too. Many people do not know that men can get breast
Your Health Matters Prostate Cancer & Its Treatment By the UCSF Medical Center Prostate Cancer Advocates Greetings! From our personal experience in dealing with our own prostate cancers, we UCSF Patient
Information for Men Receiving Radiation and Hormone Treatments for Prostate Cancer Treatment Plan Stage of prostate cancer: RADIATION THERAPY Radiation Treatments: Date for planning CT: Date to start radiation
Breast Cancer Introduction Cancer of the breast is the most common form of cancer that affects women but is no longer the leading cause of cancer deaths. About 1 out of 8 women are diagnosed with breast
PROSTATE CANCER 101 WHAT IS PROSTATE CANCER? Prostate cancer is cancer that begins in the prostate. The prostate is a walnut-shaped gland in the male reproductive system located below the bladder and in
PSA Testing 101 Stanley H. Weiss, MD Professor, UMDNJ-New Jersey Medical School Director & PI, Essex County Cancer Coalition firstname.lastname@example.org September 23, 2010 Screening: 3 tests for PCa A good screening
Your consent to our cookies if you continue to use this website.